Literature DB >> 11463572

Peroxisome proliferator-activated receptor-gamma: from adipogenesis to carcinogenesis.

L Fajas1, M B Debril, J Auwerx.   

Abstract

Peroxisome proliferator-activated receptors (PPARs) are nuclear hormone receptors, initially described as molecular targets for synthetic compounds inducing peroxisome proliferation. PPAR-gamma, the best characterized of the PPARs, plays a crucial role in adipogenesis and insulin sensitization. Furthermore, PPAR-gamma has been reported to affect cell proliferation/differentiation pathways in various malignancies. We discuss in the present review recent advances in the understanding of the function of PPAR-gamma in both cell proliferation and adipocyte differentiation.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11463572     DOI: 10.1677/jme.0.0270001

Source DB:  PubMed          Journal:  J Mol Endocrinol        ISSN: 0952-5041            Impact factor:   5.098


  66 in total

Review 1.  Correction of dysfunctional fatty acid metabolism using peroxisome proliferator activated receptor gamma agonists.

Authors:  Nicholas D Oakes; Bengt Ljung; Germán Camejo
Journal:  J R Soc Med       Date:  2002       Impact factor: 5.344

2.  Intermuscular and intramuscular adipose tissues: Bad vs. good adipose tissues.

Authors:  Gary J Hausman; Urmila Basu; Min Du; Melinda Fernyhough-Culver; Michael V Dodson
Journal:  Adipocyte       Date:  2014-12-10       Impact factor: 4.534

3.  Modulation of muscle regeneration, myogenesis, and adipogenesis by the Rho family guanine nucleotide exchange factor GEFT.

Authors:  Brad A Bryan; Dianne C Mitchell; Lei Zhao; Wenbin Ma; Lewis J Stafford; Ba-Bie Teng; Mingyao Liu
Journal:  Mol Cell Biol       Date:  2005-12       Impact factor: 4.272

Review 4.  The role of peroxisome proliferator-activated receptor gamma in diabetes and obesity.

Authors:  Francesco S Celi; Alan R Shuldiner
Journal:  Curr Diab Rep       Date:  2002-04       Impact factor: 4.810

5.  Peroxisome proliferator-activated receptor-gamma activated by ligands can inhibit human lung cancer cell growth through induction of apoptosis.

Authors:  Min Zhang; Ping Zou; Ming Bai; Yang Jin; Xiaonan Tao
Journal:  J Huazhong Univ Sci Technolog Med Sci       Date:  2003

6.  Rosiglitazone and 15-deoxy-Delta12,14-prostaglandin J2, ligands of the peroxisome proliferator-activated receptor-gamma (PPAR-gamma), reduce ischaemia/reperfusion injury of the gut.

Authors:  Salvatore Cuzzocrea; Barbara Pisano; Laura Dugo; Angela Ianaro; Nimesh S A Patel; Rosanna Di Paola; Tiziana Genovese; Prabal K Chatterjee; Massimo Di Rosa; Achille P Caputi; Christoph Thiemermann
Journal:  Br J Pharmacol       Date:  2003-08-11       Impact factor: 8.739

7.  Effects of ciglitazone and troglitazone on the proliferation of human stomach cancer cells.

Authors:  Chan Woo Cheon; Dae Hwan Kim; Dong Heon Kim; Yong Hoon Cho; Jae Hun Kim
Journal:  World J Gastroenterol       Date:  2009-01-21       Impact factor: 5.742

8.  Effect of growth factors on the proliferation and gene expression of human meibomian gland epithelial cells.

Authors:  Shaohui Liu; Wendy R Kam; Juan Ding; Mark P Hatton; David A Sullivan
Journal:  Invest Ophthalmol Vis Sci       Date:  2013-04-05       Impact factor: 4.799

9.  Associations between C1431T and Pro12Ala variants of PPARγ gene and their haplotypes with susceptibility to metabolic syndrome in an Iranian population.

Authors:  Hassan Rooki; Monir-sadat Haerian; Pedram Azimzadeh; Reza Mirhafez; Mahmoud Ebrahimi; Gordon Ferns; Majid Ghayour-Mobarhan; Mohammad-Reza Zali
Journal:  Mol Biol Rep       Date:  2014-01-28       Impact factor: 2.316

10.  miR-17-92 cluster accelerates adipocyte differentiation by negatively regulating tumor-suppressor Rb2/p130.

Authors:  Qiang Wang; Yan Chun Li; Jinhua Wang; Juan Kong; Yuchen Qi; Richard J Quigg; Xinmin Li
Journal:  Proc Natl Acad Sci U S A       Date:  2008-02-19       Impact factor: 11.205

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.